387 related articles for article (PubMed ID: 26427624)
1. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
[TBL] [Abstract][Full Text] [Related]
2. Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.
Gyberg V; Kotseva K; Dallongeville J; Backer GD; Mellbin L; Rydén L; Wood D; Bacquer DD;
Eur J Prev Cardiol; 2015 Jun; 22(6):753-61. PubMed ID: 24691153
[TBL] [Abstract][Full Text] [Related]
3. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
[TBL] [Abstract][Full Text] [Related]
4. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention of coronary artery disease in contemporary clinical practice.
Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
[TBL] [Abstract][Full Text] [Related]
6. Difficulties in reaching therapeutic goals for hypertension and dysplipidaemia in patients with type 2 diabetes in general practice.
Knudsen ST; Mosbech TH; Hansen B; Kønig E; Johnsen PC; Kamper AL
Dan Med J; 2013 Dec; 60(12):A4740. PubMed ID: 24355449
[TBL] [Abstract][Full Text] [Related]
7. Only a minority of patients referred for elective coronary artery bypass surgery have risk factors diagnosed and treated according to established guidelines.
Anderson RE; Brismar K; Ivert T
Diab Vasc Dis Res; 2007 Jun; 4(2):112-6. PubMed ID: 17654444
[TBL] [Abstract][Full Text] [Related]
8. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey.
Heuschmann PU; Kircher J; Nowe T; Dittrich R; Reiner Z; Cifkova R; Malojcic B; Mayer O; Bruthans J; Wloch-Kopec D; Prugger C; Heidrich J; Keil U
Eur J Prev Cardiol; 2015 Oct; 22(10):1354-62. PubMed ID: 25139770
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.
Leśniak W; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jankowski M; Sieradzki J; Banasiak W;
Cardiol J; 2015; 22(2):150-9. PubMed ID: 25299503
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
Poussa H; Strandberg TE; Tikkanen I; Kauhanen P; Lepäntalo M
Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
[TBL] [Abstract][Full Text] [Related]
11. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
[TBL] [Abstract][Full Text] [Related]
12. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
[TBL] [Abstract][Full Text] [Related]
13. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
14. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
15. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
[TBL] [Abstract][Full Text] [Related]
16. [Differentiated treatment of diabetics with an acute coronary syndrome].
Hamm CW; Hamann A
Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
[No Abstract] [Full Text] [Related]
17. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
EUROASPIRE II Study Group
Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
[TBL] [Abstract][Full Text] [Related]
18. Heartwatch: a secondary prevention programme in primary care in Ireland.
Bennett K; Jennings S; Collins C; Boland M; Leahy J; Bedford D; Shelley E
Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):651-6. PubMed ID: 19177599
[TBL] [Abstract][Full Text] [Related]
19. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Reiner Z; Keil U;
Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):530-40. PubMed ID: 20577089
[TBL] [Abstract][Full Text] [Related]
20. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
Ferdinand KC
J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
